Strategic Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.2M | Sell |
44,492
-1,638
| -4% | -$352K | 2.45% | 11 |
|
|
2026
Q1 | $10M | Sell |
46,130
-1,033
| -2% | -$229K | 1.67% | 11 |
|
|
2025
Q4 | $10.8M | Sell |
47,163
-1,113
| -2% | -$254K | 1.69% | 12 |
|
|
2025
Q3 | $11.2M | Buy |
48,276
+257
| +0.5% | +$52.3K | 1.8% | 12 |
|
|
2025
Q2 | $8.91M | Sell |
48,019
-2,314
| -5% | -$430K | 1.75% | 12 |
|
|
2025
Q1 | $10.5M | Sell |
50,333
-1,397
| -3% | -$272K | 2.03% | 10 |
|
|
2024
Q4 | $9.19M | Sell |
51,730
-2,552
| -5% | -$469K | 1.66% | 14 |
|
|
2024
Q3 | $10.7M | Sell |
54,282
-4,784
| -8% | -$893K | 2% | 9 |
|
|
2024
Q2 | $10.1M | Sell |
59,066
-5,089
| -8% | -$843K | 1.97% | 9 |
|
|
2024
Q1 | $11.7M | Buy |
64,155
+3,628
| +6% | +$625K | 2.3% | 9 |
|
|
2023
Q4 | $9.38M | Sell |
60,527
-17,929
| -23% | -$2.61M | 1.78% | 13 |
|
|
2023
Q3 | $11.7M | Buy |
78,456
+1,615
| +2% | +$237K | 2.31% | 11 |
|
|
2023
Q2 | $10.4M | Sell |
76,841
-820
| -1% | -$120K | 1.97% | 12 |
|
|
2023
Q1 | $12.4M | Buy |
77,661
+998
| +1% | +$153K | 2.51% | 10 |
|
|
2022
Q4 | $12.4M | Sell |
76,663
-3,042
| -4% | -$466K | 2.76% | 8 |
|
|
2022
Q3 | $10.7M | Sell |
79,705
-41
| -0.1% | -$5.88K | 2.37% | 10 |
|
|
2022
Q2 | $12.2M | Sell |
79,746
-1,301
| -2% | -$199K | 2.55% | 9 |
|
|
2022
Q1 | $13.1M | Sell |
81,047
-2,887
| -3% | -$419K | 2.28% | 10 |
|
|
2021
Q4 | $11.4M | Buy |
83,934
+5,973
| +8% | +$706K | 1.62% | 13 |
|
|
2021
Q3 | $8.41M | Buy |
77,961
+14,712
| +23% | +$1.68M | 1.81% | 12 |
|
|
2021
Q2 | $7.12M | Buy |
63,249
+626
| +1% | +$70.5K | 1.85% | 11 |
|
|
2021
Q1 | $6.78M | Buy |
62,623
+7,730
| +14% | +$827K | 1.97% | 11 |
|
|
2020
Q4 | $5.86M | Buy |
54,893
+3,824
| +7% | +$367K | 1.69% | 16 |
|
|
2020
Q3 | $4.49M | Buy |
51,069
+443
| +0.9% | +$41.7K | 1.51% | 17 |
|
|
2020
Q2 | $4.95M | Buy |
50,626
+22,975
| +83% | +$2.02M | 1.85% | 15 |
|
|
2020
Q1 | $2.17M | Buy |
27,651
+6,767
| +32% | +$576K | 0.95% | 24 |
|
|
2019
Q4 | $1.85M | Buy |
20,884
+4,662
| +29% | +$387K | 0.64% | 44 |
|
|
2019
Q3 | $1.23M | Buy |
16,222
+9,266
| +133% | +$635K | 0.46% | 58 |
|
|
2019
Q2 | $505K | Sell |
6,956
-238
| -3% | -$18.7K | 0.19% | 94 |
|
|
2019
Q1 | $580K | Sell |
7,194
-10,692
| -60% | -$875K | 0.22% | 92 |
|
|
2018
Q4 | $1.65M | Sell |
17,886
-673
| -4% | -$59.2K | 0.72% | 36 |
|
|
2018
Q3 | $1.75M | Sell |
18,559
-1,877
| -9% | -$178K | 0.64% | 43 |
|
|
2018
Q2 | $1.89M | Sell |
20,436
-25,784
| -56% | -$2.52M | 0.76% | 36 |
|
|
2018
Q1 | $4.38M | Buy |
46,220
+66
| +0.1% | +$7.25K | 1.81% | 15 |
|
|
2017
Q4 | $4.46M | Sell |
46,154
-791
| -2% | -$74.5K | 1.82% | 16 |
|
|
2017
Q3 | $4.17M | Buy |
46,945
+416
| +0.9% | +$31.7K | 1.81% | 14 |
|
|
2017
Q2 | $3.37M | Sell |
46,529
-566
| -1% | -$38.1K | 1.54% | 19 |
|
|
2017
Q1 | $3.07M | Buy |
47,095
+436
| +0.9% | +$27.4K | 1.45% | 21 |
|
|
2016
Q4 | $2.92M | Buy |
46,659
+249
| +0.5% | +$15.2K | 1.53% | 16 |
|
|
2016
Q3 | $2.93M | Buy |
46,410
+432
| +0.9% | +$28K | 1.64% | 15 |
|
|
2016
Q2 | $2.85M | Sell |
45,978
-4,126
| -8% | -$251K | 1.64% | 14 |
|
|
2016
Q1 | $2.86M | Sell |
50,104
-223
| -0.4% | -$12.4K | 1.63% | 12 |
|
|
2015
Q4 | $2.98M | Sell |
50,327
-83
| -0.2% | -$4.78K | 1.95% | 13 |
|
|
2015
Q3 | $2.74M | Buy |
50,410
+42
| +0.1% | +$2.73K | 1.9% | 14 |
|
|
2015
Q2 | $3.38M | Buy |
50,368
+35,562
| +240% | +$2.32M | 2.16% | 10 |
|
|
2015
Q1 | $836K | Buy |
14,806
+96
| +0.7% | +$5.8K | 0.54% | 62 |
|
|
2014
Q4 | $963K | Buy |
14,710
+55
| +0.4% | +$3.47K | 0.63% | 57 |
|
|
2014
Q3 | $846K | Sell |
14,655
-151
| -1% | -$8.38K | 0.56% | 64 |
|
|
2014
Q2 | $836K | Buy |
14,806
+3,232
| +28% | +$170K | 0.53% | 62 |
|
|
2014
Q1 | $595K | Sell |
11,574
-150
| -1% | -$7.58K | 0.4% | 80 |
|
|
2013
Q4 | $619K | Sell |
11,724
-266
| -2% | -$13.1K | 0.42% | 80 |
|
|
2013
Q3 | $536K | Sell |
11,990
-1,397
| -10% | -$61.9K | 0.44% | 73 |
|
|
2013
Q2 | $557K | Buy |
+13,387
| New | +$585K | 0.5% | 65 |
|
Other funds holding ABBV
Strategic Advisors's ABBV Position: Q2 2026 in Review
Strategic Advisors reduced its AbbVie (ABBV) stake by 3.6% in Q2 2026, selling an estimated $352K and leaving 44,492 shares worth $11.2M. The position accounts for 2.45% of the portfolio, ranked #11.
Strategic Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.1M in Q1 2022. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Strategic Advisors held 44,492 shares of AbbVie worth $11.2M as of Q2 2026.
- Strategic Advisors sold 1,638 AbbVie shares in Q2 2026, an estimated $352K.
- AbbVie made up 2.45% of Strategic Advisors's portfolio in Q2 2026, its #11 holding.
- Strategic Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Strategic Advisors's AbbVie position peaked at $13.1M in Q1 2022.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Strategic Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.